5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies

4:59 INITIATIVE

4:59 is 5AM’s hands-on internal effort to discover, incubate, and fund breakthrough science. We seek to partner alongside academics and entrepreneurs – often serving as an extension of the operating team – to establish proof-of-concept data that will enable a Series A Financing.

VENTURE CAPITAL

5AM Ventures Strategy primarily invests in private therapeutic companies. The funds are typically early-stage focused, with an emphasis on Series A companies.

PUBLIC EQUITY

5AM Opportunities Strategy invests in small and mid-cap public and later-stage private biotech and life science companies.

Scroll Down
Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science

Pushing the healthcare industry forward

  • Under Management
    $ 0 B
    Capital Raised Since Inception
    Data as of January 1, 2024

    We’re a life science venture capital firm founded in 2002 and currently investing $450M from 5AM Ventures VII and $300M from 5AM Opportunities II.

  • Under Management
    0
    PORTFOLIO COMPANIES

    Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.

  • Under Management
    0
    ONGOING CLINICAL TRIALS

    Historically our portfolio companies have had over 80,000 patients enrolled across 8,000 test sites in clinical trials.

San Francisco, CA
Boston, MA